IR Biosciences Holdings, Inc.
IRBS
$0.00
$0.000.00%
OTC PK
| 12/31/2010 | 09/30/2010 | 06/30/2010 | 03/31/2010 | 12/31/2009 | |
|---|---|---|---|---|---|
| Net Income | 87.70% | -336.16% | 135.52% | -555.02% | 124.17% |
| Total Depreciation and Amortization | -10.00% | -4.76% | -12.50% | -11.11% | -18.18% |
| Total Amortization of Deferred Charges | 278.76% | -67.78% | 3.51% | 2.15% | 3.71% |
| Total Other Non-Cash Items | -127.83% | 206.38% | -186.47% | 251.15% | -177.83% |
| Change in Net Operating Assets | -7.25% | -19.75% | 69.25% | 399.30% | 212.78% |
| Cash from Operations | -- | -- | 100.00% | 44.66% | 26.12% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | 100.00% | 44.66% | 26.12% |